Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
John Craig Thompson currently holds 79,873 shares of Trius Therapeutics Inc (TSRX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, John Craig Thompson has been a net seller of TSRX stock. They have purchased $27.0K and sold $4.0M worth of shares.
John Craig Thompson's most recent insider trade was on May 28, 2026, when they sold 79,873 shares at $0.00 per share.
John Craig Thompson serves as Executive at Trius Therapeutics Inc (TSRX). They have executed 19 insider transactions totaling $4.0M over their tenure at the company.
John Craig Thompson holds the position of Executive at Trius Therapeutics Inc, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 15 years and currently hold a stake valued at $0.
John Craig Thompson has shown a selling trading pattern, with $27.0K in total purchases and $4.0M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by John Craig Thompson was on May 15, 2015, when they sold $1.2M worth of TTPH shares. This transaction involved 30,000 shares at $39.63 per share.
John Craig Thompson currently owns 79,873 shares of Trius Therapeutics Inc (TSRX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of John Craig Thompson's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. John Craig Thompson has 19 Form 4 filings on record as an insider at Trius Therapeutics Inc.
Set alerts for John Craig Thompson and 40,000+ other insiders.